Market Overview:
The global angiotensin II receptor market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of hypertension and other cardiovascular diseases, rising geriatric population, and growing demand for novel therapeutics. By type, the C-21 segment is expected to account for the largest share of the market in 2018. By application, immunology is expected to account for the largest share of the market in 2018. Geographically, North America is estimated to dominate the global angiotensin II receptor market in 2018.
Product Definition:
The angiotensin II receptor is a type of receptor found on the surface of cells. It is activated by the hormone angiotensin II, which causes the cells to contract. The receptor is important for regulating blood pressure and fluid balance.
C-21:
C-21 is also known as angiotensin II receptor, it's a protein that enables the entry of angiotensin II into cells. The blood pressure raising effect of captopril is due to its ability to bind with the sites on the kidney and liver. C-21 has been studied in patients who have suffered from chronic renal failure and were found to be able to help raise blood pressure when added back into their bodies.
EMA-401:
EMA-401 is a selective and competitive inhibitor of the human EMT1A (KIT) receptor. It has been studied in combination with an angiotensin II receptor 1 (R1) antagonist in Phase 2b clinical studies for the treatment of hypertension.
Application Insights:
The acute ischemic stroke segment held the largest revenue share of 24.0% in 2017. The application of angiotensin II receptor type 1 (Ang II-1) has been studied in patients suffering from acute ischemic stroke as compared to those who do not suffer from this condition. It has been found that the use of Ang II-1 reduces the infarct size and improves neurological survival time as compared to controls, which provides a strong therapeutic potential for its use in treating patients suffering from acute ischemic stroke.
The immunology segment held a significant revenue share owing to several clinical trials that have proved its efficiency against various autoimmune disorders such as rheumatoid arthritis, lupus, multiple sclerosis.
Regional Analysis:
North America dominated the global market in 2017. High prevalence of hypertension, stroke, and heart failure is anticipated to drive the regional demand for AT2Rx drugs. In addition, increasing R&D investment by major players coupled with rising number of clinical trials in this region is expected to fuel growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to high unmet medical needs coupled with rapidly improving healthcare infrastructure and economic development in emerging countries such as China and India. Moreover, growing awareness regarding target disease management along with favorable government initiatives are some factors that can be attributed for rapid expansion of market share held by C-21 angiotensin II receptor type 1 (AT2R) specific ligands such as candesartan cilexetil (Effient) and olmesartan medoxomil (Benlysta).
Growth Factors:
- Increasing prevalence of hypertension and other cardiovascular diseases
- Growing geriatric population
- Rising awareness about the benefits of angiotensin II receptor blockers therapy
- Technological advancements in the field of angiotensin II receptor blocker drugs development
- Availability of generic versions of branded angiotensin II receptor blocker drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Angiotensin II Receptor Market Research Report
By Type
C-21, EMA-401, KDT-501, MOR-107, Others
By Application
Immunology, Respiratory, Women's Health, Acute Ischemic Stroke, Others
By Companies
CJ HealthCare Corp, MorphoSys AG, Novartis AG, Vicore Pharma AB, CJ HealthCare Corp
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
188
Number of Tables & Figures
132
Customization Available
Yes, the report can be customized as per your need.
Global Angiotensin II Receptor Market Report Segments:
The global Angiotensin II Receptor market is segmented on the basis of:
Types
C-21, EMA-401, KDT-501, MOR-107, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Immunology, Respiratory, Women's Health, Acute Ischemic Stroke, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CJ HealthCare Corp
- MorphoSys AG
- Novartis AG
- Vicore Pharma AB
- CJ HealthCare Corp
Highlights of The Angiotensin II Receptor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- C-21
- EMA-401
- KDT-501
- MOR-107
- Others
- By Application:
- Immunology
- Respiratory
- Women's Health
- Acute Ischemic Stroke
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Angiotensin II Receptor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Angiotensin II receptor is a protein that binds to angiotensin II, a hormone that regulates blood pressure and fluid balance.
Some of the major companies in the angiotensin ii receptor market are CJ HealthCare Corp, MorphoSys AG, Novartis AG, Vicore Pharma AB, CJ HealthCare Corp.
The angiotensin ii receptor market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Angiotensin II Receptor Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Angiotensin II Receptor Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Angiotensin II Receptor Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Angiotensin II Receptor Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Angiotensin II Receptor Market Size & Forecast, 2020-2028
4.5.1 Angiotensin II Receptor Market Size and Y-o-Y Growth
4.5.2 Angiotensin II Receptor Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 C-21
5.2.2 EMA-401
5.2.3 KDT-501
5.2.4 MOR-107
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Immunology
6.2.2 Respiratory
6.2.3 Women's Health
6.2.4 Acute Ischemic Stroke
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Angiotensin II Receptor Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Angiotensin II Receptor Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 C-21
9.6.2 EMA-401
9.6.3 KDT-501
9.6.4 MOR-107
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Immunology
9.10.2 Respiratory
9.10.3 Women's Health
9.10.4 Acute Ischemic Stroke
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 C-21
10.6.2 EMA-401
10.6.3 KDT-501
10.6.4 MOR-107
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Immunology
10.10.2 Respiratory
10.10.3 Women's Health
10.10.4 Acute Ischemic Stroke
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 C-21
11.6.2 EMA-401
11.6.3 KDT-501
11.6.4 MOR-107
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Immunology
11.10.2 Respiratory
11.10.3 Women's Health
11.10.4 Acute Ischemic Stroke
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 C-21
12.6.2 EMA-401
12.6.3 KDT-501
12.6.4 MOR-107
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Immunology
12.10.2 Respiratory
12.10.3 Women's Health
12.10.4 Acute Ischemic Stroke
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 C-21
13.6.2 EMA-401
13.6.3 KDT-501
13.6.4 MOR-107
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Immunology
13.10.2 Respiratory
13.10.3 Women's Health
13.10.4 Acute Ischemic Stroke
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Angiotensin II Receptor Market: Competitive Dashboard
14.2 Global Angiotensin II Receptor Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 CJ HealthCare Corp
14.3.2 MorphoSys AG
14.3.3 Novartis AG
14.3.4 Vicore Pharma AB
14.3.5 CJ HealthCare Corp
